KEROS THERAPEUTICS IN

Keros Therapeutics Announces Participation at Bank of America 2025 Global Healthcare Conference

12 مايو 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Reinforces Commitment to Maximizing Stockholder Value

08 مايو 2025 17:31:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

06 مايو 2025 16:01:42 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Review of Strategic Alternatives

10 أبريل 2025 06:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers

31 مارس 2025 06:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

28 فبراير 2025 17:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

26 فبراير 2025 16:01:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

30 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept

21 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial

15 يناير 2025 06:30:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

12 ديسمبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition

09 ديسمبر 2024 19:30:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept

03 ديسمبر 2024 07:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

26 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

06 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

05 نوفمبر 2024 09:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

16 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

12 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

03 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

28 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire